Outcomes
SECONDARY, PATHOLOGY
The primary outcome measure was HbA1c (Nutripath Integrative Pathology Service, Victoria, Australia). Participants were sent Nutripath HbA1c test kits in the mail, which they returned by mail to the pathology centre for assessment. Self-reported secondary outcomes were changes in anti-glycaemic medications, quantified based on potency and dosage using the Medication Effect Score (MES) [